⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Sharad GhamandeM.D.

Obstetrics & Gynecology · Augusta, GA 30912

NPI: 1174500128

Share:

33

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peersHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

335

Total Claims

$280K

Drug Cost

98

Beneficiaries

$2,852

Cost/Patient

Risk Score Breakdown 33/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8

Score components are additive. Read full methodology

Peer Comparison vs. 22,639 Obstetrics & Gynecology providers

+2275%

Opioid rate vs peers

30.4% vs 1.3% avg

+658%

Cost per patient vs peers

$2,852 vs $376 avg

-4%

Brand preference vs peers

11.6% vs 12.1% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 2,275% above the average for Obstetrics & Gynecology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

💰

Cost per patient is 658% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

30.4%

Opioid Rate

102

Opioid Claims

$2,583

Opioid Cost

18.6%

Long-Acting Rate

This provider's opioid prescribing rate of 30.4% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

88% generic

Brand: 39 claims · $274K

Generic: 296 claims · $5,982

Patient Profile

70

Avg Age

100%

Female

1.92

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About